• to decreased the risk of critical cardiovascular (coronary heart and blood vessel) problems in Grownups with variety 2 diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk posted a research on scientific journal Mother nature a few novel glucose-sensitive insulin NNC2215 that may cut down the chance of hypoglycemia in animal product